Department of Medicine, Faculty of Medicine, Pavillon Ferdinand-Vandry, 1050, Ave de la Médecine, Université Laval, Québec, Qc G1V 0A6, Canada.
Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, 217 - 2176 Health, Sciences Mall, University of British Columbia, Vancouver, BC. V6T 1Z3, Canada.
Biochem Biophys Res Commun. 2021 Feb 12;540:56-60. doi: 10.1016/j.bbrc.2020.12.103. Epub 2021 Jan 12.
BACKGROUND/AIMS: Sex dependent differences in coronary artery vasoregulation may be due to variations in responses to endogenous vasoactive compounds including endothelin (ET-1) and nitric oxide (NO).
Septal coronary arteries (<200 μm) from healthy, sexually mature male, female and ovariectomized (i.e. surgical menopause) Sprague-Dawley rats were used. Myogenic tone, measured by pressure myography, was initially determined for all vessel segments studied before and after exposure to the nonselective ET/ET receptor blocker, bosentan (1 μM). Vasoconstrictor responses (vascular endothelium intact) to cumulative ET-1 (10 - 10 M) were assessed in a separate set of septal coronary vessels. Additional studies, examined the vasoconstrictor effects of ET-1 after NO blockade with L-NAME (200 μM).
Myogenic tone was 26 ± 7% in male, 20 ± 7% in female (p = 0.04 versus male) and 24 ± 3% in ovariectomized (p = NS versus male/female) vessels. Antagonism of ET-1 receptors produced a greater reduction in myogenic tone in male, compared to female rats over a similar range of intraluminal pressure (20-80 mmHg). Robust constrictor responses to cumulative concentrations of ET-1 were observed in all vessels; however, male rats exhibited greater sensitivity to vasoconstrictor effects of ET-1. After exposure to L-NAME vessel responses to ET-1 were normalized in male and female (not studied in ovariectomized) groups.
These findings confirm marked sex differences for myogenic tone and vessel constrictor responses to ET-1 in coronary resistance vessels. Results also suggest greater sensitivity to vasoconstrictor effects of ET-1 in male coronary resistance vessels.
背景/目的:冠状动脉血管舒缩功能的性别差异可能是由于对内源性血管活性化合物(包括内皮素 [ET-1] 和一氧化氮 [NO])的反应不同所致。
使用来自健康、性成熟的雄性、雌性和去卵巢(即手术绝经)Sprague-Dawley 大鼠的间隔冠状动脉(<200μm)。使用压力肌动描记术测量所有研究血管段的肌源性张力,然后在暴露于非选择性 ET/ET 受体阻滞剂博森坦(1μM)前后确定。在另一组间隔冠状动脉中评估了累积 ET-1(10-10 M)对血管收缩反应(血管内皮完整)。进一步的研究检查了 NO 阻断剂 L-NAME(200μM)后 ET-1 的血管收缩作用。
雄性的肌源性张力为 26±7%,雌性为 20±7%(p=0.04 与雄性相比),去卵巢组为 24±3%(p=NS 与雄性/雌性相比)。在相似的管腔内压力范围(20-80mmHg)内,ET-1 受体拮抗作用使雄性大鼠的肌源性张力降低幅度大于雌性大鼠。在所有血管中均观察到累积浓度的 ET-1 引起的强烈收缩反应;然而,雄性大鼠对 ET-1 的血管收缩作用更为敏感。在暴露于 L-NAME 后,雄性和雌性(未在去卵巢组中研究)组对 ET-1 的血管反应均正常化。
这些发现证实了冠状动脉阻力血管中肌源性张力和血管收缩对 ET-1 的反应存在明显的性别差异。结果还表明,雄性冠状动脉阻力血管对 ET-1 的血管收缩作用更为敏感。